Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure.

Uthoff H, Thalhammer C, Potocki M, Reichlin T, Noveanu M, Aschwanden M, Staub D, Arenja N, Socrates T, Twerenbold R, Mutschmann-Sanchez S, Heinisch C, Jaeger KA, Mebazaa A, Mueller C.

Eur J Heart Fail. 2010 May;12(5):469-76. doi: 10.1093/eurjhf/hfq024. Epub 2010 Mar 11.

2.

N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.

Rutten JH, Steyerberg EW, Boomsma F, van Saase JL, Deckers JW, Hoogsteden HC, Lindemans J, van den Meiracker AH.

Am Heart J. 2008 Jul;156(1):71-7. doi: 10.1016/j.ahj.2008.02.021. Epub 2008 May 27.

PMID:
18585499
3.

NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality.

Bayés-Genís A, Lopez L, Zapico E, Cotes C, Santaló M, Ordonez-Llanos J, Cinca J.

J Card Fail. 2005 Jun;11(5 Suppl):S3-8.

PMID:
15948093
4.

Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study.

Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, Januzzi JL Jr.

Circ Heart Fail. 2010 May;3(3):354-61. doi: 10.1161/CIRCHEARTFAILURE.109.915280. Epub 2010 Mar 23.

5.

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure.

Harjola VP, Follath F, Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Hochadel M, Komajda M, Lopez-Sendon JL, Ponikowski P, Tavazzi L.

Eur J Heart Fail. 2010 Mar;12(3):239-48. doi: 10.1093/eurjhf/hfq002.

6.

Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure.

Xue Y, Clopton P, Peacock WF, Maisel AS.

Eur J Heart Fail. 2011 Jan;13(1):37-42. doi: 10.1093/eurjhf/hfq210. Epub 2010 Dec 13.

7.

Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.

Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas Morales W, Bayol AP, Kriskovich JO, Medina F, Gonzalez Arjol B, Brizuela M.

J Heart Lung Transplant. 2006 Oct;25(10):1230-40.

PMID:
17045936
8.

Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.

Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, Mills RM.

J Am Coll Cardiol. 2008 Aug 12;52(7):534-40. doi: 10.1016/j.jacc.2008.05.010.

9.

Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.

Januzzi JL Jr, Sakhuja R, O'donoghue M, Baggish AL, Anwaruddin S, Chae CU, Cameron R, Krauser DG, Tung R, Camargo CA Jr, Lloyd-Jones DM.

Arch Intern Med. 2006 Feb 13;166(3):315-20.

PMID:
16476871
10.
11.

Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization.

Bettencourt P, Azevedo A, Fonseca L, Araújo JP, Ferreira S, Almeida R, Rocha-Goncalves F, Ferreira A.

Int J Cardiol. 2007 Apr 12;117(1):75-9. Epub 2006 Jul 14.

PMID:
16843555
12.

Decompensated heart failure in the emergency department of a cardiology hospital.

Mangini S, Silveira FS, Silva CP, Grativvol PS, Seguro LF, Ferreira SM, Mocelin AO, Cardoso LF, Bacal F, Bocchi EA.

Arq Bras Cardiol. 2008 Jun;90(6):400-6. English, Portuguese.

13.

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.

Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, Hlavin P, Maisel AS.

Ann Emerg Med. 2002 Feb;39(2):131-8.

PMID:
11823766
14.

Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).

Shah MR, Hasselblad V, Tasissa G, Christenson RH, Binanay C, O'Connor CM, Ohman EM, Stevenson LW, Califf RM.

Am J Cardiol. 2007 Nov 1;100(9):1427-33. Epub 2007 Aug 21.

PMID:
17950802
15.

Natriuretic peptide system is not exhausted in severe heart failure.

Lourenço P, Azevedo A, Araújo JP, Bettencourt P.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):39-43.

PMID:
19708225
16.

Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.

Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.

J Am Coll Cardiol. 2008 Jun 17;51(24):2329-35. doi: 10.1016/j.jacc.2007.11.085.

17.
18.

Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.

deFilippi CR, Seliger SL, Maynard S, Christenson RH.

Clin Chem. 2007 Aug;53(8):1511-9. Epub 2007 Jun 22.

19.

A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure.

Gardner RS, Chong KS, Morton JJ, McDonagh TA.

Eur J Heart Fail. 2007 Mar;9(3):266-71. Epub 2006 Oct 4.

20.

Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?

Ezekowitz JA, Kaul P, Bakal JA, Quan H, McAlister FA.

Eur J Heart Fail. 2011 Feb;13(2):142-7. doi: 10.1093/eurjhf/hfq185. Epub 2010 Oct 19.

Supplemental Content

Support Center